1. Feasibility, effectiveness and cost of a decentralized HCV care model among the general population in Delhi, India
- Author
-
Sanjay Sarin, Philippa Easterbrook, Babu Entoor Ramachandran, Sundeep Miglani, Navneet Tewatia, Mugil Murya, Jagpreet Chhatwal, Alexander Tyshkovskiy, Jessica Markby, Mary Gaeddert, Divya Soni, Ekta Gupta, Madeline Adee, Shiv Kumar Sarin, Ryan Jose Ruiz, Sonjelle Shilton, and Preetishirin Katapur
- Subjects
Adult ,Male ,medicine.medical_specialty ,Referral ,Hepatitis C virus ,Population ,India ,Hepacivirus ,medicine.disease_cause ,Single site ,Internal medicine ,medicine ,Humans ,Hcv prevalence ,Prospective Studies ,Prospective cohort study ,education ,education.field_of_study ,Hepatology ,business.industry ,Hepatitis C ,Middle Aged ,medicine.disease ,Feasibility Studies ,Female ,business ,Viral load - Abstract
BACKGROUND AND AIMS India has a significant burden of hepatitis C virus (HCV) infection and has committed to achieving national elimination by 2030. This will require a substantial scale-up in testing and treatment. The "HEAD-Start Project Delhi" aimed to enhance HCV diagnosis and treatment pathways among the general population. METHODS A prospective study was conducted at 5 district hospitals (Arm 1: one-stop shop), 15 polyclinics (Arm 2: referral for viral load (VL) testing and treatment) and 62 screening camps (Arm 3: referral for treatment). HCV prevalence, retention in the HCV care cascade, and turn-around time were measured. RESULTS Between January and September 2019, 37 425 participants were screened for HCV. The median (IQR) age of participants was 35 (26-48) years, with 50.4% male and 49.6% female. A significantly higher proportion of participants in Arm 1 (93.7%) and Arm 3 (90.3%) received a VL test compared with Arm 2 (52.5%, P
- Published
- 2021